Microbes for lung cancer detection: feasibility and limitations

Area of Science:

• Microbiology
• Oncology
• Medical Diagnostics

Background:

• Lung cancer is a leading global malignancy, influenced by genetics, environment, and the lung microenvironment.
• Current detection methods like CT scans and biopsies have limitations, including false positives and invasiveness.
• The human microbiome plays a role in host inflammation, metabolism, and cancer development.

Purpose of the Study:

• To review current research on microbial applications for lung cancer detection.
• To identify challenges in microbial sample collection and analysis for diagnostics.
• To project future clinical benefits of microbial-based lung cancer screening.

Main Methods:

• Literature review of studies on the role of microbes in lung cancer.
• Analysis of current diagnostic techniques and their limitations.
• Exploration of emerging microbial detection strategies.

Main Results:

• Microbes are implicated in cancer development, progression, and treatment response.
• The diagnostic potential of microbes for lung cancer remains underexplored.
• Existing microbial detection methods face challenges in standardization and clinical implementation.

Conclusions:

• Microbial diagnostics present a novel avenue for non-invasive lung cancer early detection.
• Overcoming challenges in microbial sample handling and analysis is crucial for clinical translation.
• Further research is needed to validate microbial biomarkers for lung cancer screening and diagnosis.